ArticleGenes & diseases2024

In-depth profiling of tumor tissue derived from malignant pleural mesothelioma patients identifies potential biomarkers predicting response to immune-checkpoint inhibitor therapy.

Dmitrii Shek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.